Research analysts at StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a report issued on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Athersys Price Performance ATHX stock opened at $0.02 on Thursday. Athersys has a twelve month low of $0.01 and a twelve month high […]
StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report released on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Price Performance ATHX stock opened at $0.02 on Tuesday. Athersys has a 52 week low of $0.01 and a 52 week high of $1.99. The […]
StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report report published on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance Shares of NASDAQ:ATHX opened at $0.02 on Tuesday. The company’s fifty day moving average is $0.02 and its two-hundred day moving […]
StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report sent to investors on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Price Performance NASDAQ:ATHX opened at $0.03 on Monday. The firm’s 50-day moving average price is $0.02 and its 200-day moving average price […]
StockNews.com started coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a report published on Sunday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Athersys Trading Down 51.1 % ATHX stock opened at $0.01 on Friday. The firm has a market cap of $407,352.00, a P/E ratio of 0.00 and […]